Timothy L. Moore's Net Worth

$5.15 Million

Estimate Recalculated Apr 24, 2024 03:20PM EST

Who is Timothy L. Moore?

Timothy L. Moore has an estimated net worth of $5.15 Million. This is based on reported shares across multiple companies, which include Allogene Therapeutics, Inc., Kite Pharma, Inc., CERUS CORP, Instil Bio, Inc., and BIOLIFE SOLUTIONS INC.

SEC CIK

Timothy L. Moore's CIK is 0001669207

Past Insider Trading and Trends

2020 was Timothy L. Moore's most active year for acquiring shares with 6 total transactions. Timothy L. Moore's most active month to acquire stocks was the month of May. 2017 was Timothy L. Moore's most active year for disposing of shares, totalling 15 transactions. Timothy L. Moore's most active month to dispose stocks was the month of July. 2017 saw Timothy L. Moore paying a total of $404,190.00 for 17,000 shares, this is the most they've acquired in one year. In 2017 Timothy L. Moore cashed out on 336,100 shares for a total of $20,812,932.03, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Allogene Therapeutics, Inc. (ALLO) Snapshot price: $4.13

Chief Technical Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-6.14%
-17.36K
$3.47
-$60,188.86
265.46K
Apr 22
Form 4
+51.87%
96.6K
—
—
282.82K
Jan 25
Form 4
∞
186.22K
—
—
186.22K
Apr 24
Form 3
—
0
—
—
0
No matching records found

Kite Pharma, Inc. No price found

EVP, Technical Operations

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-45.66K
$180.00
—
0
Oct 3
Form 4
-7.57%
-3.74K
$118.01
-$1,385,360.38
45.66K
Mar 15 - Sep 25
Form 4
—
0
$77.49
-$390,883.45
49.4K
Scheduled
Aug 3
Form 4
-15.41%
-9.00K
$76.30
-$1,157,591.95
49.4K
Scheduled
Aug 1
Form 4
+16.80%
8.4K
—
—
58.4K
Dec 22
Form 4
∞
50K
—
—
50K
Mar 15
Form 3
—
0
—
—
0
No matching records found

CERUS CORP (CERS) Snapshot price: $2.215

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+61.47%
40K
$5.00
$200,000.00
105.07K
Jun 7
Form 4
+45.84%
20.45K
—
—
65.07K
Jun 1
Form 4
+10.65%
4.3K
—
—
44.62K
Sep 5
Form 4
+230.33%
28.12K
—
—
40.32K
Jun 1 - Jun 2
Form 4
+54.30%
4.3K
—
—
12.21K
Sep 5
Form 4
—
0
—
—
0
Jun 3
Form 4
+84.11%
3.61K
$4.75
$17,165.05
7.91K
Feb 11
Form 4/A
—
0
—
—
4.3K
Jan 29
Form 4
+84.11%
3.61K
$4.15
$14,998.10
7.91K
Jan 29
Form 4
∞
4.3K
—
—
4.3K
Sep 5
Form 4
—
0
—
—
0
Jun 5
Form 4
—
0
—
—
0
Sep 5
Form 3
—
0
—
—
0
No matching records found

Instil Bio, Inc. (TIL) Snapshot price: $11.94

Chief Operating Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 6
Form 3
—
0
—
—
0
No matching records found

BIOLIFE SOLUTIONS INC (BLFS) Snapshot price: $18.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+60.45%
11.26K
—
—
29.9K
Mar 8
Form 4
+2.73%
495
—
—
18.63K
Nov 1
Form 4
+2.04%
362
—
—
18.14K
Oct 1
Form 4
+134.23%
10.19K
—
—
17.78K
Jan 3
Form 4
∞
7.59K
—
—
7.59K
Sep 1
Form 3
—
0
—
—
0
No matching records found